Operator error means some could miss out on $100,000 or more in Provider Relief Fund payments
By
Kimberly Bonvissuto
Jun 07, 2022
Provider error could mean the loss of $100,000 or more in Provider Relief Fund monies for some senior living organizations.
Sharing lessons from the pandemic
By
Lois A. Bowers
Jun 06, 2022
Brookdale Senior Living President and CEO Lucinda “Cindy” Baier discusses her new book, “Heroes Work Here: An Extraordinary Story of Courage, Resilience and Hope from the Front Lines of COVID-19.”
With questions about whether any further COVID-19 relief legislation will be passed this year, Argentum said Tuesday that it is focusing on a federal workplace safety rule, financial relief and workforce...
Multisystem abnormalities persist after COVID-19 hospitalization
May 31, 2022
Persisting evidence of cardio-renal involvement and hemostasis pathway activation was reported at 28 to 60 days after discharge.
COVID-19 can ‘rebound’ after treatment with Paxlovid, CDC says
May 24, 2022
In these cases, the illness improved or resolved within an average of three days.
Antibody levels after COVID-19 vaccination inversely linked to body weight
May 23, 2022
An inverse correlation was sustained for up to six months following two doses of BNT162b2 (Pfizer–BioNTech) in a small cohort of healthy young and middle-aged adults.
Loss of smell, taste less likely with newer COVID-19 variants
May 18, 2022
A lower risk for developing chemosensory loss was observed with the alpha, delta and omicron variants.
With no targeted relief on horizon, Argentum seeks various avenues of financial support for senior living
By
Kimberly Bonvissuto
Apr 28, 2022
With no apparent additional targeted COVID-19 financial relief on the horizon for the assisted living industry, Argentum is continuing its push to have providers included in proposed relief packages for...
Major airlines drop mask mandate after federal judge rules against it
Apr 19, 2022
The U.S. Transportation Security Administration will stop enforcing the mandate for now.
Adverse effects generally mild after BNT162b2 mRNA booster in over 60s
Apr 18, 2022
Thirty percent of those aged 60 years or older receiving a booster reported at least one adverse event; few sought medical attention.